Versiti in Traverse City and Munson Healthcare are still actively seeking donations of COVID-19 convalescent plasma to treat people who are hospitalized with the disease.

Munson has been a participant of the U.S. Food and Drug Administration-led trial in partnership with the Mayo Clinic since May. Seven months later, doctors say more than 300 locals have received the treatment with anecdotal evidence showing significant reductions in the time it takes to recover from the disease both locally and nationally.

 The FDA authorized the treatment for emergency use in August.

“It’s been very active and something we’ve felt very good about both in the community for donating and in the hospital as a hope for treatment,” said Dr. William Kanner, a pathologist that practices at Munson and serves as its pathology section chief.